1. Introduction {#sec0005}
===============

Solitary pancreatic metastases of gastric cancer are extremely rare, and only a few cases have been reported \[[@bib0005], [@bib0010], [@bib0015], [@bib0020], [@bib0025], [@bib0030], [@bib0035], [@bib0040], [@bib0045], [@bib0050]\]. The radiological features of solitary pancreatic metastases of gastric cancer resemble those of ductal carcinoma of pancreas, rendering preoperative diagnosis difficult \[[@bib0055]\]. The clinicopathological features of pancreatic metastasis of gastric cancer have not been fully defined. Therefore, we present a case of solitary pancreatic metastasis of gastric cancer with synchronous primary pancreatic ductal carcinoma. We review previous cases and discuss the clinicopathological features of pancreatic metastasis of gastric cancer. The case report described herein is in line with the SCARE criteria \[[@bib0060]\].

2. Presentation of case {#sec0010}
=======================

An 86-year old man presented with a poorly enhanced tumor of pancreatic body and dilation of the main pancreatic duct seen on computed tomography (CT). Two and half years prior, he had undergone total gastrectomy, with Roux-en-Y reconstruction for gastric adenocarcinoma in our hospital. He had no remarkable medical or family history. The primary gastric cancer was located in the cardia, measuring 9 cm in the largest diameter. Microscopically, it was a non-solid type poorly differentiated adenocarcinoma, mixed with signet-ring cell adenocarcinoma and moderately differentiated tubular adenocarcinoma invading through the submucosa. No lymphatic vessel invasion was detected; however, there was venous invasion. No lymph node metastasis was found. The gastric carcinoma was completely resected. No recurrence was detected during regular follow-up.

Two and a half years after resection, CT revealed a hypovascular mass accompanied with dilation of the peripheral pancreatic duct in the pancreatic body ([Fig. 1](#fig0005){ref-type="fig"}). No other masses were detected. Because of the diagnosis of pancreatic cancer, open distal pancreatosplenectomy was performed. Intraoperative findings revealed a hard mass in the pancreatic body. The transverse mesocolon firmly adhered to the pancreas and the retroperitoneum around the pancreas had become very hard. It was very difficult to separate the pancreas from the mesocolon completely; therefore, the transverse mesocolon was partly resected together. No apparent peritoneal dissemination was detected. The resected tumor measured 25 × 20 × 25 mm^3^ and was a white to yellowish, firm mass ([Fig. 2](#fig0010){ref-type="fig"}a) Microscopy revealed poorly differentiated adenocarcinoma cells mixed with moderately differentiated tubular adenocarcinoma cells whose features were inconsistent with the gastric cancer specimen resected earlier ([Fig. 2](#fig0010){ref-type="fig"}b, c). The tumor cells infiltrated from this tumor into the fat tissue of the retroperitoneum around the pancreas extensively, and the surgical margin was positive because of these fat tissues. Retrospectively, this cancer cell invasion was considered the probable reason for retroperitoneum being so hard intraoperatively. No lymphatic vessel invasion was detected; however, there was venous vessel invasion. Proximal to the metastasis of the gastric cancer, 7 mm distal from the stump, well-differentiated tubular adenocarcinoma existed in the pancreatic duct and invaded surrounding tissues ([Fig. 2](#fig0010){ref-type="fig"}d). This well-differentiated adenocarcinoma was near but separated from the metastasis of gastric cancer. Furthermore, the degree of differentiation was different from the gastric cancer resected before. Based on these characteristics, this well-differentiated adenocarcinoma was considered to be pancreatic ductal carcinoma. The postoperative course was uneventful. However, 6 months after surgery, CT revealed peritoneal dissemination. He died from recurrence 10 months after the surgery.Fig. 1Preoperative computed tomography (CT). (a) Yellow arrow indicates poorly enhanced tumor of the pancreatic body. (b) Red arrow indicates the dilated main pancreatic duct.Fig. 1Fig. 2(a) Gross appearance of the resected specimen. The dimensions were 25 × 20 × 25 mm^3^ (b, c) Histopathological appearance of the primary gastric cancer (b) and resected pancreatic tumor (c). Photograph revealing that both tumors were composed of poorly differentiated adenocarcinoma cells, mixed with moderately differentiated tubular adenocarcinoma cells. (d) Histopathological appearance of invasive ductal carcinoma. Well-differentiated adenocarcinoma found in the pancreatic duct.Fig. 2

3. Discussion {#sec0015}
=============

Secondary tumors of the pancreas are rare. In autopsy surveys with malignant neoplasms, the prevalence of pancreatic metastasis has been reported to range from 1.6--11% \[[@bib0065]\]. The most common primary sites reported were lung followed by gastrointestinal tract, especially stomach, kidney, and breast \[[@bib0065]\]. Nevertheless, in the autopsy series, almost all studies included tumors that directly invaded the pancreas as secondary pancreatic tumors; this is probably the reason why the stomach has a high percentage of the primary sites of pancreatic metastasis \[[@bib0065],[@bib0070]\]. When pancreatic metastasis is limited to solitary metastatic tumor in the pancreas, pancreatic metastasis of gastric cancer is extremely rare. To our knowledge, only four cases have been reported in English literature \[[@bib0005], [@bib0010], [@bib0015], [@bib0020]\]. Because of the high prevalence of gastric cancer in Japan, six cases have been reported in the Japanese literature; including our case, 11 cases of solitary pancreatic metastasis of gastric cancer are reviewed and discussed below ([Table 1](#tbl0005){ref-type="table"}\]) \[[@bib0025], [@bib0030], [@bib0035], [@bib0040], [@bib0045], [@bib0050]\].Table 1Histopathological features of solitary pancreatic metastasis of gastric cancer.Table 1Primary gastric cancerAuthorAge/ genderDepthNlyvHisto-logyDurationPreoperative DiagnosisPancreatic duct dilationPrognosisBrannigan67/FMPn.d.n.d.n.d.sig120Mn.d.(-)12MNakai59/Mn.d.(+)(+)(-)porsynchroPK(-)2M died (PE)Wente60/FSS(+)n.d.n.d.por48MPK or metan.d.12MRolandn.d.n.d.n.d.n.d.n.d.n.d.n.d.PKn.d.n.d.Kondo72/MSS(-)n.d.n.d.mod7MPK or meta(-)72 M diedHashimoto77/MSE(+)(+)(+)ud10MPK or meta(-)14MTeshima68/MSS(+)n.d.n.d.modsynchroIntraoperative(-)14MNakae50/FMP(+)(+)(+)mod12Mmeta(-)48MMatsumoto72/MSS(+)(+)(-)por46MIPMC(-)12MWatanabe75/MSS(+)(-)(+)mod48MPK(-)7Mours86/MSS(-)(-)(+)por31MIPMC(+)10 M died[^1]

When gastric cancer metastasizes to the pancreas, either the hematogenous or the lymphatic pathway is considered. Of the nine patients, primary gastric cancer accompanied with lymph node metastasis occurred in seven. Lymphatic pathway has been considered to be dominant in metastasis of gastric cancer to the pancreas because the lymphatic vessel of stomach and that of pancreas are closely connected. Nevertheless, in our case, there was no lymph node metastasis and no lymphatic invasion in the primary tumor. This suggests that the pancreatic metastasis in our case was probably hematogenous metastasis from gastric cancer.

Favorable long-term survival after surgical resection of pancreatic metastasis has been reported \[[@bib0055]\]. However, the prognosis depends on the type of primary cancer. As for pancreatic resection of gastric cancer, long-term follow-up has been not discussed in many cases such as ours. Nevertheless, in almost all cases, over 1-year survival was achieved. The morbidity and mortality rates after pancreatic resection have greatly decreased in recent years; therefore, pancreatic resection should be considered when solitary pancreatic metastasis of gastric cancer is suspected \[[@bib0055]\].

The preoperative diagnoses of pancreatic metastasis have been challenging. Of the 11 cases, the diagnosis of pancreatic metastasis was made in only one case. Radiological features of pancreatic metastasis depend on the primary tumor \[[@bib0075]\]. In cases where the primary tumor is hypovascular, such as gastric cancer, it is difficult to differentiate primary pancreatic ductal carcinoma from secondary pancreatic tumors using radiological enhancement patterns because primary ductal adenocarcinoma also appears hypovascular. On the other hand, observations of pancreatic duct are important to differentiate pancreatic metastasis from ductal adenocarcinoma \[[@bib0080]\]. Ductal carcinoma originates from the pancreatic duct; therefore, disruption and dilation of pancreatic duct emerge in the early phase. Nevertheless, pancreatic metastasis occurs in the parenchyma of the pancreas and grows expansively; therefore, it probably takes longer to involve the pancreatic duct. Indeed, excluding our case, pancreatic dilation was not observed in any of the cases. The pancreatic duct dilation was observed in our case partly because the primary ductal adenocarcinoma coexisted with gastric metastatic adenocarcinoma. The coexistence of primary and metastatic adenocarcinoma in the pancreas is extremely rare, and to our knowledge, no such case has been reported. Considering the rarity of the coexistence of primary adenocarcinoma, pancreatic metastasis should be considered when a poorly enhanced pancreatic mass with no dilation of pancreatic duct is detected in patients with history of gastric cancer.

4. Conclusions {#sec0020}
==============

Solitary pancreatic metastasis of gastric cancer is rare; nevertheless, it should be considered when pancreatic tumor with no dilation of pancreatic duct is detected in patients with history of gastric cancer. Pancreatic resection should be considered when solitary pancreatic metastasis of gastric cancer is suspected.
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[^1]: n.d.: not documented, ud: undifferentiated adenocarcinoma, por: poorly differentiated adenocarcinoma, synchro: synchronous metastasis, PK: primary pancreatic carcinoma, meta: metastasis, PE: pulmonary emboli, IPMC: intraductal papillary mucinous carcinoma.
